CN103191304A - Traditional Chinese medicine composition for treating blood stasis type aplastic anemia - Google Patents
Traditional Chinese medicine composition for treating blood stasis type aplastic anemia Download PDFInfo
- Publication number
- CN103191304A CN103191304A CN2013101427334A CN201310142733A CN103191304A CN 103191304 A CN103191304 A CN 103191304A CN 2013101427334 A CN2013101427334 A CN 2013101427334A CN 201310142733 A CN201310142733 A CN 201310142733A CN 103191304 A CN103191304 A CN 103191304A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- blood stasis
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating blood stasis type aplastic anemia. The composition is prepared from rubia yunnanensis, embelia parviflora wall, millettia dielsiana, root of panax zingiberensis, clethra loosestrife herb, rhizoma polygonati, malaytea scurfpea fruit, common scouring rush herb, white paeony root, lilac pink herb, yerbadetajo herb and platycodon root. The composition can be clinically used for treating blood stasis type aplastic anemia.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese medicine composition, especially relate to a kind of Chinese medicine composition for the treatment of blood stasis type aplastic anemia.
Background technology
Blood stasis type aplastic anemia is a kind of different substantiality disease, is the marrow hematopoiesis function failure that causes owing to a variety of causes, shows as the anemia illness of pancytopenia.The primary disease clinical manifestation except anemia, hemorrhage, normal companion infects and heating.Have the scholar to think in recent years, the pathogenesis of chronic aplastic anemia mainly is dysimmunity.Modern medicine generally adopts blood transfusion therapy and medication combined treatments such as androgen and ciclosporin to blood stasis type aplastic anemia, but untoward reaction is heavier, is difficult to prolonged application.Long-term practice through the inventor draws, and Chinese medicine is controlled blood stasis type aplastic anemia and had better effect, obtains good effect.
Summary of the invention
The Chinese medicine composition of the treatment blood stasis type aplastic anemia that the object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, human body is had no side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilize the property of medicine of Chinese medicine uniqueness, adopt Radix Rubiae Yunnanensis, Radix seu Caulis Embeliae Parviflorae, Caulis Millettiae Reticulatae, egg seven, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), Rhizoma Polygonati, Fructus Psoraleae, Herba Equiseti Hiemalis, the Radix Paeoniae Alba, Herba Dianthi, Herba Ecliptae, Radix Platycodonis are according to certain compatibility requirement, through being processed into.
Preparing Chinese medicine composition of the present invention is made by following raw material medicaments: Radix Rubiae Yunnanensis 50-60 part, Radix seu Caulis Embeliae Parviflorae 35-45 part, Caulis Millettiae Reticulatae 30-40 part, egg seven 30-40 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20-30 part, Rhizoma Polygonati 20-30 part, Fructus Psoraleae 20-40 part, Herba Equiseti Hiemalis 10-20 part, Radix Paeoniae Alba 10-20 part, Herba Dianthi 10-20 part, Herba Ecliptae 8-10 part, Fructus Citri tangerinae ridge 5-10 part.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: 55 parts of Radix Rubiae Yunnanensis, 40 parts of Radix seu Caulis Embeliae Parviflorae, 35 parts of Caulis Millettiae Reticulataes, 7 35 parts in egg, 25 parts of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), 25 parts of Rhizoma Polygonatis, 25 parts of Fructus Psoraleaes, 15 parts of Herba Equiseties Hiemalis, 15 parts of the Radix Paeoniae Albas, 15 parts of Herba Dianthis, 9 parts of Herba Ecliptaes, 8 parts on the Fructus Citri tangerinae ridge.
The pharmacological action of Chinese medicine of the present invention is as follows:
Radix Rubiae Yunnanensis: sweet, warm.Return Liver Channel.Relaxing muscles and tendons to promote blood circulation, promoting tissue regeneration by removing blood stasis is taken good care of QI and blood.Be used for rheumatalgia, traumatic injury, anemia, menoxenia, amenorrhea, puerperal arthralgia, dizzy disease such as insomnia grade.
Radix seu Caulis Embeliae Parviflorae: bitter, puckery, warm.Return liver, kidney channel.Enrich blood, invigorate blood circulation, strong waist knee joint.Be used for all diseases of blood deficiency, menoxenia, amenorrhea, puerperal asthenia, waist and leg ache, diseases such as injury and bone fracture.
Caulis Millettiae Reticulatae: bitter, puckery, sweet, warm.Return liver, kidney channel.Tonifying blood and arresting bleeding, promoting blood circulation to remove obstruction in the collateral.Clinical weak for blood deficiency, impairment caused by overstrain muscles and bones has through uncomfortable, amenorrhea, and puerperal abdonimal pain, lochiorrhea, various hemorrhage, rheumatic arthralgia, diseases such as traumatic injury.
Egg seven: bitter, warm.Dissipating blood stasis, hemostasis, analgesic therapy.Be used for traumatic injury, interior traumatic hemorrhage, puerperal blood faints, retention of lochia, cough due to consumptive disease, diseases such as anemia.
Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis): bitter, hot, flat.Return liver, spleen channel.Clearing away heat-damp and promoting diuresis, promoting blood circulation to remove blood stasis, removing toxicity for eliminating carbuncles.Be used for edema, pyretic stranguria, jaundice, dysentery, rheumatism pyretic arthralgia, leukorrhagia, amenorrhea, traumatic injury, fracture, traumatic hemorrhage, acute mastitis, furuncle, diseases such as venom.
Rhizoma Polygonati: sweet, flat, return spleen, lung, kidney channel.Nourishing YIN and moistening the lung, invigorating the spleen and replenishing QI.Be used for lung-dryness syndrome due to deficiency of YIN, weakness of the spleen and stomach, the dizziness of deficiency of kidney essence, soreness of the waist and knees, early whitening of beard and hair and quench one's thirst etc.
Fructus Psoraleae: hot, bitter, warm.Return kidney, spleen channel.Reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal.Be used for cards such as deficiency and coldness lumbago.
Herba Equiseti Hiemalis: sweetness and bitterness, flat.Return lung, liver, gallbladder meridian.Wind and heat dispersing, cooling blood for hemostasis, improving acuity of vision and removing nebula.Be used for the wind heat conjunctival congestion, order is given birth to nebula, discharging fresh blood stool, hemorrhoidal bleeding, dysentery, married woman's metrorrhagia, proctoptosis etc.
The Radix Paeoniae Alba: bitter, sour, be slightly cold, return liver, spleen channel.Nourish blood and seek relieving spasm to stop pain, yin fluid astringing suppressing the hyperactive liver.Cure mainly the blood deficiency cold and heat, epigastric pain, it is dizzy to have a headache.
Herba Dianthi: bitter, cold.GUIXIN, small intestinal, urinary bladder channel.Inducing diuresis for treating stranguria syndrome, promoting blood circulation to restore menstrual flow.Be used for damp-heat gonorrhoea, the menoxenia alive of the amenorrhea of heat in blood stasis of blood resistance.
Herba Ecliptae: sweet, sour, cool.Return liver, kidney channel.Liver and kidney tonifying, cooling blood for hemostasis.Cure mainly deficiency of the liver and kindey, have a dizzy spell, early whitening of beard and hair is spitted blood, and has blood in stool traumatic hemorrhage etc.
Radix Platycodonis: bitter, hot, flat.Attach to the lung and stomach meridians.Lung qi dispersing, eliminate the phlegm, sore-throat relieving, evacuation of pus.Be used for cough with copious phlegm, laryngopharynx swelling and pain, lung abscess vomiting pus, the full hypochondriac pain of born of the same parents, dysentery stomachache etc.
Blood stasis type aplastic anemia according to its anemia, hemorrhage, asthenia, dizziness, clinical manifestation such as weak, belongs to motherland's medical science " asthenia ", " deficient " and " blood disorder " category.Injure the QI and blood internal organs mainly due to six climate exopathogens, seven emotions, eating and drinking without temperance, exhaustion due to sexual indulgence, evil poison etc., especially have influence on spleen, kidney and bone marrow, its pathogenesis is " be basis to suffer from a deficiency of the kidney ".Radix Rubiae Yunnanensis relaxing muscles and tendons to promote blood circulation, promoting tissue regeneration by removing blood stasis, regulating QI are nourished blood among the present invention, are monarch drug, and Radix seu Caulis Embeliae Parviflorae is enriched blood, invigorated blood circulation, Caulis Millettiae Reticulatae tonifying blood and arresting bleeding, promoting blood circulation to remove obstruction in the collateral, egg seven dissipating blood stasis, analgesic therapy are ministerial drug, the Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) promoting blood circulation to remove blood stasis, the Rhizoma Polygonati invigorating the spleen and replenishing QI, Fructus Psoraleae reinforcing the kidney and supporting YANG, Herba Equiseti Hiemalis's cooling blood for hemostasis, the Radix Paeoniae Alba joint venture of nourishing blood, the Herba Dianthi promoting blood circulation to restore menstrual flow, Herba Ecliptae liver and kidney tonifying, the pain relieving of Radix Platycodonis lung qi dispersing.All medicines share plays liver and kidney tonifying altogether, blood circulation promoting and blood stasis dispelling, and regulating QI is nourished blood, and the effect of stasis-dispelling and pain-killing is found through clinical practice, and blood stasis type aplastic anemia is had unique curative effect.
Chinese medicine composition of the present invention was in 2004 to 2009 clinical observation blood stasis type aplastic anemia 78 routine patients, and clinical report is as follows:
1, physical data
Man's 45 examples, women 33 examples at 9～65 years old age, average 33 years old, all meet blood stasis type diagnosis of aplastic anemia standard.
2, diagnostic criteria
(1) Western medicine diagnose standard: with reference to " hematopathy diagnosis and criterion of therapeutical effect " 3 editions.
1) pancytopenia, reticulocyte reduces.Lymphocyte increases relatively.
2) at least 1 position hypoplasia of bone marrow or severe lower (as active proliferation, must there be the obvious minimizing of megalokaryocyte and lymphocyte to increase relatively), bone marrow granule non-hematopoietic cell increases (person of having ready conditions does bone marrow biopsy, shows that hemopoietic tissue reduces, and fatty tissue increases).
3) cause the other diseases of pancytopenia except the energy, as pancytopenia, acute hemopoietic function stagnation, the myelofibrosis, acute from disorders of blood, malignant histocytosis etc. of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, autoantibody mediation.
(2) traditional Chinese medical science disease diagnostic criteria: with reference to " new Chinese medicine clinical research guideline " (trying).
Aplastic anemia patient lusterless complexion, dizzy weak, pale lips, onyx does not have the pool, soreness of the waist and knees, deficiency of QI with disinclination to talk, moving then tachypnea, or see bleeding tendency, subcutaneous, mouth and nose all can be hemorrhage, optical fundus visceral hemorrhage very then, and more than repeatedly, protracted course of disease, light red tongue is dark or purpura arranged, the thready and hesitant pulse person belongs to blood stasis type aplastic anemia.
4, Therapeutic Method
4.1 prescription: Radix Rubiae Yunnanensis 55g, Radix seu Caulis Embeliae Parviflorae 40g, Caulis Millettiae Reticulatae 35g, egg seven 35g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 25g, Rhizoma Polygonati 25g, Fructus Psoraleae 25g, Herba Equiseti Hiemalis 15g, Radix Paeoniae Alba 15g, Herba Dianthi 15g, Herba Ecliptae 9g, Radix Platycodonis 8g.
4.2 preparation and using method: said medicine technology is routinely made decoction, and 1 dose of every day, every day 2 times, 25 days was 1 course for the treatment of.
5, therapeutic outcome:
5.1 clinical efficacy standard: with reference to " hematopathy diagnosis and criterion of therapeutical effect " 3 editions
Cure: anemia, bleeding disappear, and hemoglobin reaches 120g/L (man) or 100g/L (woman), and numeration of leukocyte reaches 4 * 10
9/ L, platelet count reaches 80 * 10
9/ L follows up a case by regular visits to not recurrence more than 1 year.
Produce effects: anemia, bleeding disappear, and hemoglobin reaches 120g/L (man) or 100g/L (woman), and numeration of leukocyte reaches 3.5 * 10
9About/L, platelet count also has certain degree to increase, and follows up a case by regular visits to 3 months stable disease or continues progressive.
Effectively: anemia, bleeding are clearly better, and under the not blood transfusion situation, hemoglobin is treated in preceding 1 month modal value and increased more than the 30g/L, and keeps and do not fall in 3 months.
Invalid: through fully treatment, symptom, hemogram do not reach obvious progress.
5.2 result: among the 78 routine patients, cure 29 examples (37.2%), produce effects 36 examples (46.1%), effective 9 examples (11.5%), invalid 4 examples (5.2%), total effective rate is 94.8%.
6, model case
6.1 Liu, the woman, 33 years old, patient's complexion was greyish white, and the whole body is weak, the chronognosis cold extremities, dizziness, cardiopalmus has gingival hemorrhage, epistaxis, indigestion and loss of appetite lack of appetite, the peace of sleeping night, two just transfer light red tongue, white and thin fur, deep-thready pulse.Routine blood test shows: hemoglobin (HGB) 65g/L, leukocyte (WBC) 2.0 * 10
9/ L, erythrocyte (RBC) 2.9 * 10
12/ L, platelet (PLT) 22 * 10
9/ L.Bone marrow (ilium) puncture is shown: three is that hypertrophy is bad, meets blood stasis type aplastic anemia bone marrow smear, and biopsy is shown: grain, red, huge three is that cell reduces, and adipose cell increases.Take medicine of the present invention, treat 1 course for the treatment of, patient's subjective symptoms takes a turn for the better, and the whole body is unable more precedingly slightly take a favorable turn, and limbs are temperature gradually, does when dizzy, has half congealed thinly during stool, and the tongue arteries and veins is the same, and routine blood test shows: HGB90g/L, WBC3.4 * 10
9/ L, RBC3.8 * 10
12/ L, PLT50 * 10
9/ L.Continue to take 2 courses for the treatment of, patient's symptom takes a turn for the better, and the whole body is still strong, and anemia before has clear improvement, do not have dizzy, receive can, the peace of sleeping night, two just accent, light red tongue, white and thin fur, thready pulse.Routine blood test shows: HGB105g/L, WBC4.3 * 10
9/ L, RBC4.2 * 10
12/ L, PLT85 * 10
9/ L.Recovery from illness was followed up a case by regular visits to 1 year, and conditions of patients is stable, during go treatment of blood transfusion.
6.2 the Wang, the man, 35 years old,, patient's lusterless complexion, skin mucosa is dispersed in the petechia, gingival hemorrhage, epistaxis, dizziness, tinnitus, soreness of the waist and knees is unable, the time xerostomia, receive can, the peace of sleeping night still is hard and dry, urine is normal, tongue is dim red, white and thin fur, thready pulse.Routine blood test shows: HGB59g/L, WBC2.1 * 10
9/ L, RBC2.8 * 10
12/ L, PLT19 * 10
9/ L; Bone marrow examination is shown: grain system, red be that hypertrophy is all low, do not see megalokaryocyte, meet blood stasis type aplastic anemia bone marrow smear.First quarter moon blood transfusion at present 1 time.Take medicine of the present invention, treat 1 course for the treatment of, subjective symptoms takes a turn for the better, and anemia is more preceding slightly to be improved, and skin mucosa does not have the petechia, the time whole body weak, dizziness, receive can, the peace of sleeping night, two just accent, the tongue arteries and veins is the same.Routine blood test shows: HGB80g/L, WBC3.0 * 10
9/ L, RBC3.6 * 10
12/ L, PLT56 * 10
9/ L, during blood transfusion prolong blanking time.Continue to take 2 courses for the treatment of, subjective symptoms is obviously improved, and skin mucosa is not seen the petechia, and the whole body is strong, does not have symptoms such as dizziness, soreness of the waist and knees, receive can, the peace of sleeping night, two just accent, light red tongue, white and thin fur, rolling pulse.Routine blood test shows: HGB119g/L, WBC4.1 * 10
9/ L, RBC4.6 * 10
12/ L, PLT83 * 10
9/ L, during go treatment of blood transfusion, recovery from illness.Followed up a case by regular visits to 1 year, conditions of patients is stable.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment, and following this embodiment only for explanation the present invention to the present invention without limits.
Embodiment 1, a kind of Chinese medicine composition for the treatment of blood stasis type aplastic anemia, be that Herba Ecliptae 8g, Radix Platycodonis 5g make by Radix Rubiae Yunnanensis 50g, Radix seu Caulis Embeliae Parviflorae 35g, Caulis Millettiae Reticulatae 30g, egg seven 30g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20g, Rhizoma Polygonati 20g, Fructus Psoraleae 20g, Herba Equiseti Hiemalis 10g, Radix Paeoniae Alba 10g, Herba Dianthi 10g.
Embodiment 2, a kind of Chinese medicine composition for the treatment of blood stasis type aplastic anemia, be that Herba Ecliptae 9g, Radix Platycodonis 8g make by Radix Rubiae Yunnanensis 55g, Radix seu Caulis Embeliae Parviflorae 40g, Caulis Millettiae Reticulatae 35g, egg seven 35g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 25g, Rhizoma Polygonati 25g, Fructus Psoraleae 25g, Herba Equiseti Hiemalis 15g, Radix Paeoniae Alba 15g, Herba Dianthi 15g.
Embodiment 3, a kind of Chinese medicine composition for the treatment of blood stasis type aplastic anemia, be that Herba Ecliptae 10g, Radix Platycodonis 10g make by Radix Rubiae Yunnanensis 60g, Radix seu Caulis Embeliae Parviflorae 45g, Caulis Millettiae Reticulatae 40g, egg seven 40g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 30g, Rhizoma Polygonati 30g, Fructus Psoraleae 40g, Herba Equiseti Hiemalis 20g, Radix Paeoniae Alba 20g, Herba Dianthi 20g.
Claims (2)
1. Chinese medicine composition for the treatment of blood stasis type aplastic anemia is characterized in that it is to be made by following raw material medicaments:
Radix Rubiae Yunnanensis 50-60 part, Radix seu Caulis Embeliae Parviflorae 35-45 part, Caulis Millettiae Reticulatae 30-40 part, egg seven 30-40 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20-30 part, Rhizoma Polygonati 20-30 part, Fructus Psoraleae 20-40 part, Herba Equiseti Hiemalis 10-20 part, Radix Paeoniae Alba 10-20 part, Herba Dianthi 10-20 part, Herba Ecliptae 8-10 part, Fructus Citri tangerinae ridge 5-10 part.
2. Chinese medicine composition according to claim 1 is characterized in that it is to be made by following raw material medicaments:
55 parts of Radix Rubiae Yunnanensis, 40 parts of Radix seu Caulis Embeliae Parviflorae, 35 parts of Caulis Millettiae Reticulataes, 7 35 parts in egg, 25 parts of Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis), 25 parts of Rhizoma Polygonatis, 25 parts of Fructus Psoraleaes, 15 parts of Herba Equiseties Hiemalis, 15 parts of the Radix Paeoniae Albas, 15 parts of Herba Dianthis, 9 parts of Herba Ecliptaes, 8 parts on the Fructus Citri tangerinae ridge.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101427334A CN103191304A (en) | 2013-04-10 | 2013-04-10 | Traditional Chinese medicine composition for treating blood stasis type aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101427334A CN103191304A (en) | 2013-04-10 | 2013-04-10 | Traditional Chinese medicine composition for treating blood stasis type aplastic anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103191304A true CN103191304A (en) | 2013-07-10 |
Family
ID=48714238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101427334A Pending CN103191304A (en) | 2013-04-10 | 2013-04-10 | Traditional Chinese medicine composition for treating blood stasis type aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103191304A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111249349A (en) * | 2020-03-19 | 2020-06-09 | 重庆市中药研究院 | Application of Damnacanthus indicus and/or loosestrife in preparation of medicine for treating aplastic anemia |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138480A (en) * | 1996-01-23 | 1996-12-25 | 田振典 | "Weixuekang", a medicine for blood health |
| CN1539459A (en) * | 2003-10-30 | 2004-10-27 | 吉林省辽源亚东药业股份有限公司 | Chinese materia medica preparation of recreating blood for curing anaemia and producing method |
| CN102078511A (en) * | 2010-12-30 | 2011-06-01 | 山西振东制药股份有限公司 | Medicine for promoting leukopoiesis |
| CN102370754A (en) * | 2010-08-11 | 2012-03-14 | 叶志平 | Traditional Chinese medicine preparation for treating headache due to deficiency of blood |
-
2013
- 2013-04-10 CN CN2013101427334A patent/CN103191304A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138480A (en) * | 1996-01-23 | 1996-12-25 | 田振典 | "Weixuekang", a medicine for blood health |
| CN1539459A (en) * | 2003-10-30 | 2004-10-27 | 吉林省辽源亚东药业股份有限公司 | Chinese materia medica preparation of recreating blood for curing anaemia and producing method |
| CN102370754A (en) * | 2010-08-11 | 2012-03-14 | 叶志平 | Traditional Chinese medicine preparation for treating headache due to deficiency of blood |
| CN102078511A (en) * | 2010-12-30 | 2011-06-01 | 山西振东制药股份有限公司 | Medicine for promoting leukopoiesis |
Non-Patent Citations (12)
| Title |
|---|
| 《上海中医药杂志》 20011231 李春有等 "木贼治崩漏" , 第9期 * |
| 《中医杂志》 20110531 胡晓梅等 "周霭祥诊治再生障碍性贫血的学术思想" 第52卷, 第9期 * |
| 《吉林中医药》 20101231 魏学礼等 "周永明膏方治疗慢性再生障碍性贫血经验" 第30卷, 第12期 * |
| 《河北化工》 20111031 姚东云等 "珍珠菜的药理作用和临床应用研究进展" 第34卷, 第10期 * |
| 《浙江中医学院学报》 19991231 汪玉冠等 "活血化瘀在再生障碍性贫血中的应用研究" 第23卷, 第6期 * |
| 《黑龙江中医药》 20091231 宋兴武 "活血化瘀治疗再生障碍性贫血应用概述" , 第4期 * |
| 姚东云等: ""珍珠菜的药理作用和临床应用研究进展"", 《河北化工》, vol. 34, no. 10, 31 October 2011 (2011-10-31) * |
| 宋兴武: ""活血化瘀治疗再生障碍性贫血应用概述"", 《黑龙江中医药》, no. 4, 31 December 2009 (2009-12-31) * |
| 李春有等: ""木贼治崩漏"", 《上海中医药杂志》, no. 9, 31 December 2001 (2001-12-31) * |
| 汪玉冠等: ""活血化瘀在再生障碍性贫血中的应用研究"", 《浙江中医学院学报》, vol. 23, no. 6, 31 December 1999 (1999-12-31) * |
| 胡晓梅等: ""周霭祥诊治再生障碍性贫血的学术思想"", 《中医杂志》, vol. 52, no. 9, 31 May 2011 (2011-05-31) * |
| 魏学礼等: ""周永明膏方治疗慢性再生障碍性贫血经验"", 《吉林中医药》, vol. 30, no. 12, 31 December 2010 (2010-12-31) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111249349A (en) * | 2020-03-19 | 2020-06-09 | 重庆市中药研究院 | Application of Damnacanthus indicus and/or loosestrife in preparation of medicine for treating aplastic anemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101658645B (en) | Cool bath lotion composition, preparation method and application thereof in preparing medicaments and health products for treating fire type exhaustion syndrome or obesity | |
| CN104857288B (en) | Treat the Chinese medicine preparation and preparation method thereof of white hair | |
| CN102908474B (en) | Medicinal liquor for treating neurosis | |
| CN105012772A (en) | Traditional Chinese medicine preparation for rectal prolapses and preparation method of preparation | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN103550539B (en) | Chinese medicinal composition for treating hypertension | |
| CN105381411A (en) | Medicine for treating epilepsy and preparation method of medicine | |
| CN109453314A (en) | A kind of Chinese medicine composition fumigated for gynaecology's postoperative rehabilitation | |
| CN104013836B (en) | A kind of Chinese medicine composition treating cerebral apoplexy sequela | |
| CN103549829A (en) | Traditional Chinese medicine pillow for treating cerebral thrombosis | |
| CN103585609A (en) | Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof | |
| CN103191304A (en) | Traditional Chinese medicine composition for treating blood stasis type aplastic anemia | |
| CN111888450A (en) | Foot bath medicine composition for preventing and treating female cold stagnation and blood stasis dysmenorrhea and preparation method thereof | |
| CN103169853B (en) | Traditional Chinese medicine composition for treating kidney yin deficiency type aplastic anemia | |
| CN103211978A (en) | Chinese medicine composition for treating kidney-yang deficiency type aplastic anemia | |
| CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
| CN102973882A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN102824506A (en) | Traditional Chinese medicine preparation for treating aplastic anemia | |
| CN102600388B (en) | Traditional Chinese herbal medicine for treating threatened abortion of livestock | |
| CN106075022A (en) | A kind of enema treating neonatal scleredema | |
| CN105535278A (en) | Traditional Chinese medicine capsules used for postpartum care of pregnant women | |
| CN103784713A (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin type aplastic anemia | |
| CN112138121A (en) | Foot-bathing traditional Chinese medicine composition for preventing and treating kidney-qi deficiency type dysmenorrhea of women | |
| CN104707029B (en) | A kind of Chinese medicine for treating psoriasis | |
| CN105147861A (en) | Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130710 |